Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2023 (2)
  • 2022 (5)

Subject

  • Take Back Day (24)
  • Drug Trafficking (23)
  • Prescription Drugs (19)
  • Outreach/Drug Prevention (18)
  • Public and Media Affairs - also see Congressional Affairs (16)
  • Congressional Affairs (12)
  • Press Conferences (11)
  • Synthetic drugs (11)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Arrests/Convictions - Major (8)
  • Red Ribbon (8)
  • Diversion Division (7)
  • Fentanyl Awareness (7)
  • Major Law Enforcement Operation (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Guns/Weapons (5)
  • Money Laundering (5)
  • OCDETF/Task Force (5)
  • One Pill Can Kill (5)
  • Intergovernmental Affairs (4)
  • Critical Incident (3)
  • Extraditions (3)
  • International/Foreign Operations (3)
  • Narcoterrorism (3)
  • Overdose (3)
  • Seizures (Drugs/Property) (3)
  • Gangs (2)
  • Scam Calls (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Museum and Visitors Center (1)
  • Task Forces/Task Force Officers (1)
  • Fake Pills (9)
  • Recruitment/Office of Training/Graduations (0)

Drug Name

  • Fentanyl (8)
  • Methamphetamine (1)

Field Division

  • Seattle (167)
  • New England (87)
  • Washington, DC (46)
  • St. Louis (32)
  • El Paso (27)
  • Houston (27)
  • Phoenix (18)
  • Rocky Mountain (18)
  • Dallas (16)
  • Miami (15)
  • Omaha (15)
  • Atlanta (12)
  • Chicago (12)
  • Los Angeles (11)
  • New York (11)
  • San Diego (9)
  • New Jersey (8)
  • San Francisco (7)
  • Louisville (6)
  • New Orleans (4)
  • Philadelphia (1)
  • Headquarters (9)
Clear All Results
PRESS RELEASE

DEA Seizes Record-Breaking 2.7 Million Fentanyl Pills

May 06, 2025
U.S. Attorney General Pam Bondi joined DEA Leadership, and the men and women of the DEA El Paso Field Division, on Tuesday, May 6, 2025 to announce the single largest seizure of fentanyl pills in DEA history. During an enforcement operation the last week of April, agents from the DEA...
May 06, 2025
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

February 26, 2024
WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
February 26, 2024
PRESS RELEASE

13 Additional Defendants Charged in Fentanyl Distribution Network that Spanned from California to D.C.

November 20, 2023
WASHINGTON – Federal and local law enforcement announced the arrests of 11 more alleged members of a fentanyl drug distribution network responsible for bringing hundreds of thousands of fake Oxycodone (M30) pills from California to D.C. Today's announcement was made by DEA Administrator Anne Milgram, U.S. Attorney Matthew M. Graves...
November 20, 2023
PRESS RELEASE

DEA Operation Last Mile Tracks Down Sinaloa and Jalisco Cartel Associates Operating within the United States

May 05, 2023
WASHINGTON – Today, the U.S. Drug Enforcement Administration announced the results of a year-long national operation, “Operation Last Mile,” targeting operatives, associates, and distributors affiliated with the Sinaloa and Jalisco Cartels responsible for the last mile of fentanyl and methamphetamine distribution on our streets and on social media. DEA’s top...
May 05, 2023
PRESS RELEASE

Drug Enforcement Administration Announces the Seizure of Over 379 million Deadly Doses of Fentanyl in 2022

December 20, 2022
WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...
December 20, 2022
PRESS RELEASE

DEA Announces Results of Enforcement Surge to Reduce the Fentanyl Supply Across the United States

September 27, 2022
WASHINGTON – The U.S. Drug Enforcement Administration today announced the results of an enforcement operation that spanned from May to September and resulted in significant fentanyl seizures across the United States. As part of the One Pill Can Kill initiative, the DEA and its law enforcement partners seized more than...
September 27, 2022
PRESS RELEASE

DEA Warns of Brightly-Colored Fentanyl Used to Target Young Americans

August 30, 2022
WASHINGTON – The Drug Enforcement Administration is advising the public of an alarming emerging trend of colorful fentanyl available across the United States. Since August 2022, DEA and our law enforcement partners seized brightly-colored fentanyl and fentanyl pills in 26 states. Dubbed “rainbow fentanyl” in the media, this trend appears...
August 30, 2022
PRESS RELEASE

President Biden Releases National Drug Control Strategy to Save Lives, Expand Treatment, and Disrupt Trafficking

April 21, 2022
WASHINGTON, D.C. – Today, President Joe Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have reached a record high. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic...
April 21, 2022
PRESS RELEASE

DEA Warns of Increase in Mass-Overdose Events Involving Deadly Fentanyl

April 06, 2022
WASHINGTON – Today, the Drug Enforcement Administration sent a letter to federal, state, and local law enforcement partners warning of a nationwide spike in fentanyl-related mass-overdose events. Administrator Anne Milgram outlined the current threat and offered DEA support to law enforcement officers responding to these tragic incidents. “Fentanyl is killing...
April 06, 2022
Showing 1 - 9 of 9 results

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español